An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.
According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next 12 months.
An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.
The newly formed company (valued at $1.05b USD) will center on funding the firm’s decentralized trial technology platform and exploring new opportunities,
The two technology companies plan to work together to provide a unified platform that serves to streamline workflow, RWE generation and data harmonization.
The GoGetTested response operating system, to date used to administer more than 200,000 tests, now will scale to include health systems in more states.
